Published in J Med Chem on October 01, 1977
Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists. J Med Chem (2013) 0.78
Comment on "Phase diagram of a solution undergoing inverse melting". Phys Rev E Stat Nonlin Soft Matter Phys (2009) 0.75
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
MedMiner: an Internet text-mining tool for biomedical information, with application to gene expression profiling. Biotechniques (1999) 5.56
EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol (1985) 2.71
Cardio-selective beta-blockade. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 2.33
Molecular evidence that the myxozoan protists are metazoans. Science (1994) 2.29
Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome. N Engl J Med (1972) 2.21
Treatment of primary hyperparathyroidism. Am J Med (1974) 1.98
Primary hyperparathyroidism: a prospective clinical study. Am J Med (1971) 1.93
Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev (1968) 1.88
Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation (1998) 1.74
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest (1971) 1.68
The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med J (1967) 1.54
Cytotoxic efficiency and effect on tumour growth of heterospecific antilymphocytic and antitumour sera. Nature (1970) 1.51
Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth. Nature (1968) 1.47
L-glyceric aciduria. A new genetic variant of primary hyperoxaluria. N Engl J Med (1968) 1.41
The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis (1988) 1.36
Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med (1994) 1.36
Disorders of oxalate metabolism. Am J Med (1968) 1.34
Effects of freezing on marrow stem cell suspensions: interactions of cooling and warming rates in the presence of PVP, sucrose, or glycerol. Cryobiology (1970) 1.30
Government and academic health science centers. West J Med (1993) 1.26
Intussusception: analysis of 98 cases. Br J Surg (1981) 1.25
Clinical features and management of cystinuria. Mayo Clin Proc (1977) 1.25
The in vitro transcription units of bacteriophage phiX174. II. In vitro initiation sites of phiX174 transcription. J Mol Biol (1976) 1.19
Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects. Ann Intern Med (1972) 1.18
Extranuclear estrogen-regulated destabilization of Xenopus laevis serum albumin mRNA. Mol Endocrinol (1989) 1.15
The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol (1983) 1.14
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int (2001) 1.13
Nucleotide sequences of the 5' termini of phi X174 mRNAs synthesized in vitro. Nucleic Acids Res (1974) 1.12
Thyroid cancer in pregnancy. Int J Gynaecol Obstet (2005) 1.10
Endometriosis-related malignancies. Int J Gynecol Cancer (2003) 1.09
Progress with enhancing veterinary surveillance in the United Kingdom. Vet Rec (2007) 1.07
A urinary peptide with extraordinary inhibitory powers against biological "calcification" (deposition of hydroxyapatite crystals). Trans Assoc Am Physicians (1966) 1.07
Anaerobic bacteria in the urinary tract. Mayo Clin Proc (1972) 1.06
FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN. J Clin Invest (1948) 1.05
Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading. Am J Physiol (1985) 1.02
Laxative abuse as a cause for ammonium urate renal calculi. J Urol (1990) 1.01
Treatment of primary hyperoxaluria. Mod Treat (1967) 1.01
The in vitro transcription units of bacteriophage phiX174. III. Initiation with specific 5' end oligonucleotides of in vitro phiX174 RNA. J Mol Biol (1976) 1.00
Potentiation of butylated hydroxytoluene-induced acute lung damage by oxygen. Cell kinetics and collagen metabolism. Am Rev Respir Dis (1983) 0.99
Deficiency of 2-oxo-glutarate: glyoxylate carboligase activity in primary hyperoxaluria. Proc Natl Acad Sci U S A (1967) 0.98
The metabolic error in primary hyperoxaluria. Arch Dis Child (1965) 0.98
Modified nucleosides in urine: selective removal and analysis. Clin Chem (1976) 0.97
Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol (1975) 0.96
Epitaxial relationships in urolithiasis: the brushite-whewellite system. Clin Sci Mol Med (1977) 0.96
Alan Gregg memorial lecture. Medical education for the 21st century. J Med Educ (1985) 0.96
T-type and L-type calcium currents in freshly dispersed human uterine smooth muscle cells. Am J Obstet Gynecol (1993) 0.96
Goniometric reliability for a child with spastic quadriplegia. J Pediatr Orthop (1985) 0.96
Physiological basis of differential strontium accumulation in two barley genotypes. Plant Physiol (1966) 0.95
The determination of pentosans in the analysis of woods: The gravimetric determination of furfuraldehyde. Biochem J (1937) 0.95
The in vitro transcription units of bacteriophage phiX174. I. Characterization of synthetic parameters and measurement of transcript molecular weights. J Mol Biol (1976) 0.95
Symposium on stones. Introduction. Books in the running brooks, sermons in stone. Am J Med (1968) 0.95
Hydroxyprolinemia. 3. The origin of free hydroxyproline in hydroxyprolinemia. Collagen turnover. Evidence for biosynthetic pathway in man. Biochim Biophys Acta (1968) 0.94
Soft-tissue profile change associated with surgical correction of the prognathic mandible. Am J Orthod (1974) 0.94
Estrogen regulation of Xenopus laevis gamma-fibrinogen gene expression. Biochemistry (1990) 0.94
Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab (1980) 0.94
Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases. Am J Med (1991) 0.93
Beta-adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols. J Med Chem (1968) 0.93
Acquired hyperoxaluria and intestinal disease. Evidence that bile acid glycine is not a precursor of oxalate. Mayo Clin Proc (1973) 0.93
Chemical softness and acute metal toxicity in mice and Drosophila. Toxicol Appl Pharmacol (1982) 0.92
Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria. Clin Sci (Lond) (1984) 0.92
Percutaneous lithotripsy. J Urol (1983) 0.91
Suture entrapment and secondary ureteral obstruction. Am J Obstet Gynecol (1991) 0.91
Diagnosis of primary hyperparathyroidism. Surg Clin North Am (1977) 0.91
Condylomata acuminata. Roles of different techniques of laser vaporization. J Reprod Med (1993) 0.91
Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system. Clin Sci Mol Med (1975) 0.90
Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria). Am J Kidney Dis (1994) 0.90
Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer (2004) 0.90
Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. J Lab Clin Med (1985) 0.89
Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2. J Nephrol (1998) 0.87
Cloning and characterization of bys1, a temperature-dependent cDNA specific to the yeast phase of the pathogenic dimorphic fungus Blastomyces dermatitidis. Infect Immun (1994) 0.87
The renal clearance of oxalate in normal subjects and patients with primary hyperoxaluria. Clin Sci (1971) 0.87
Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide. J Clin Endocrinol Metab (1980) 0.87
Altered morphology in cultured rat intestinal epithelial IEC-6 cells is associated with alkaline phosphatase expression. Tissue Cell (2003) 0.86
The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest Urol (1976) 0.85
Biomedical research and national policy. J Clin Invest (1970) 0.85
Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites. J Lab Clin Med (1982) 0.84
Renal brush border membrane adaptation to phosphorus deprivation: effects of fasting versus low-phosphorus diet. Kidney Int (1980) 0.84
Beta-adrenergic blocking agents. I. Pronethalol and related N-alkyl and N-aralkyl derivatives of 2-amino-1-(2-naphythyl)ethanol. J Med Chem (1968) 0.84
Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies. Gynecol Oncol (1990) 0.83
Pathogenesis of renal stones. Miner Electrolyte Metab (1987) 0.83
Inhibitors of crystal growth of hydroxyapatite: a constant composition approach. J Urol (1985) 0.83
Growth of calcium oxalate crystals. I. A model for urinary stone growth. Invest Urol (1975) 0.83
Role of ultrasound in medical management of patients with renal stone disease. Urol Radiol (1992) 0.82
Xenopus laevis serum albumin: sequence of the complementary deoxyribonucleic acids encoding the 68- and 74-kilodalton peptides and the regulation of albumin gene expression by thyroid hormone during development. Mol Endocrinol (1989) 0.82
Metabolic and clinical disturbances in patients with calcium urolithiasis. Scand J Urol Nephrol Suppl (1980) 0.82
Effect of small doses of syngeneic bone marrow on the 30- and 90-day LD50 of X-irradiated mice. Radiat Res (1969) 0.82
Urinary excretion of isethionic acid in man. Nature (1967) 0.81
EFFECTS OF HYPOXIA AND HYPERCAPNIA ON PERCEPTION OF THERMAL CUTANEOUS PAIN. J Clin Invest (1948) 0.81
Symposium on renal lithiasis. Medical evaluation of urolithiasis. Etiologic aspects and diagnostic evaluation. Urol Clin North Am (1974) 0.81
Long-term followup in patients with cystine urinary calculi treated by percutaneous ultrasonic lithotripsy. J Urol (1988) 0.81
Strain A mouse pulmonary tumor test results for chemicals previously tested in the National Cancer Institute carcinogenicity tests. J Natl Cancer Inst (1986) 0.81
New treatment for struvite urinary stones. N Engl J Med (1984) 0.81
Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanism. Science (1971) 0.81
Pyrimidine metabolism in man. N Engl J Med (1973) 0.81
Binding of benzo [a]pyrene to epidermal DNA and RNA as detected by synchronous luminescence spectrometry at 77 K. J Biochem Biophys Methods (1980) 0.81
Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephroitc syndrome. Mayo Clin Proc (1975) 0.81
Beta-adrenergic blocking agents. 10. (3-amino-2-hydroxypropoxy)anilides. J Med Chem (1971) 0.80
Skin tumorigenic potential of crude and refined coal liquids and analogous petroleum products. Fundam Appl Toxicol (1987) 0.80
Oxalate and glycolate synthesis by hemic cells. J Lab Clin Med (1971) 0.80